$210.57
▲ +0.0% Today
as of Jul 22, 16:54 ET
Last 30 days
Recent Press Releases & News
STE: Raising target price to $233.00
Stephens Adjusts STERIS Price Target to $240 From $270, Maintains Overweight Rating
STERIS' Quarterly Earnings Preview: What You Need to Know
Overview
52-week range
$195
$269
21% of range
Avg surprise (last 3)
+1.9%
Avg reaction (last 2)
-2.1%
0% positive
Latest IV / EM
34%
EM ±7.7% · $210 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 11, 2026 | Mar/2026 | $2.83 | $2.86 | -1.1% | +3.3% | -2.7% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $1.96 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $1.94 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $2.34 | $2.32 | +0.9% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $2.74 | $2.59 | +5.8% | — | -1.6% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $1.75 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $1.51 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $1.46 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $1.42 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $1.16 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $1.25 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | $2.54 | $2.34 | +8.6% |
Financials
Income statement (quarterly)
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.50B | $1.46B | $1.39B | — | $1.37B | $1.33B | $1.28B | — |
| Cost of revenue | $841M | $814M | $763M | — | $760M | $750M | $707M | — |
| Gross profit | $656M | $646M | $628M | — | $610M | $579M | $572M | — |
| Operating income | $273M | $266M | $246M | — | $245M | $220M | $186M | — |
| Net income | $193M | $192M | $177M | — | $174M | $150M | $145M | — |
| EPS (diluted) | $1.96 | $1.94 | $1.79 | — | $1.75 | $1.51 | $1.46 | — |
Balance sheet (quarterly)
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $424M | $319M | $280M | $172M | $155M | $172M | $198M | $207M |
| Inventory | $674M | $658M | $641M | $581M | $650M | $689M | $699M | $675M |
| Total current assets | $2.29B | $2.11B | $2.06B | $2.00B | $1.90B | $1.94B | $1.94B | $2.87B |
| Total assets | $10.59B | $10.41B | $10.40B | $10.15B | $10.01B | $10.24B | $10.11B | $11.06B |
| Long-term debt | $1.90B | $1.90B | $1.90B | $1.92B | $2.04B | $2.16B | $2.24B | $3.12B |
| Total liabilities | $3.42B | $3.39B | $3.44B | $3.53B | $3.58B | $3.63B | $3.74B | $4.75B |
| Total equity | $7.15B | $7.01B | $6.96B | $6.60B | $6.42B | $6.59B | $6.35B | $6.30B |